FindMyKOL
Clinical trialNCT06078566TerminatedPhase 1/PHASE2Interventional

Long-Term Follow-Up Study of Unilateral Microtia Patients Implanted With AUR-201

SponsorAuregen Biotherapeutics, SAEnrollment1Microtia
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Long-term follow-up of unilateral microtia patients implanted with AUR-201.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Romo Plastic Surgery

    New York, New York, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
26 Jan 2024
Primary completion
14 Nov 2025
Completion
14 Nov 2025
Last update posted
21 Nov 2025
Registered enrollment
1
Registry id
NCT06078566

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.